Childhood Acute Lymphoblastic Leukemia — Trials

Childhood Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

401 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 42
Ph III recruiting: 2
Growth YoY: —
Industry share: 6%
Top sponsor: Nationwide Children's Hospital
Termination share: 14%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 51–58 of 58 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00077467	Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia	completed	Phase 1	36	National Cancer Institute (NCI)NIH	1	Jun 5, 2013	clinicaltrials
NCT00079404	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia	completed	Phase 1	36	National Cancer Institute (NCI)NIH	1	Jun 5, 2013	clinicaltrials